AF
TMO icon

Align Financial’s Thermo Fisher Scientific TMO Stock Holding History

Align Financial’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.53K Hold
19
– – ﹤0.01% 263
2026
Q1 		$9.34K Sell
19
-10,991
-100% -$5.96M 0.01% 270
2025
Q4 		$11K Buy
+11,010
New +$6.23M 0.01% 267

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Align Financial's TMO Position: Q2 2026 in Review

Align Financial held its Thermo Fisher Scientific (TMO) position steady in Q2 2026 at 19 shares worth $9.53K. The position accounts for ﹤0.01% of the portfolio, ranked #263.

Align Financial first reported a position in TMO in Q4 2025 and has held it in 3 quarters since. The position peaked at $11K in Q4 2025. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Align Financial held 19 shares of Thermo Fisher Scientific worth $9.53K as of Q2 2026.
  • Align Financial left its Thermo Fisher Scientific share count unchanged in Q2 2026.
  • Thermo Fisher Scientific made up ﹤0.01% of Align Financial's portfolio in Q2 2026, its #263 holding.
  • Align Financial first reported a position in Thermo Fisher Scientific in Q4 2025 and has held it in 3 quarters since.
  • Align Financial's Thermo Fisher Scientific position peaked at $11K in Q4 2025.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Align Financial's 13F filing for Q2 2026, filed 27 Jul 2026.